Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Schwartz, Gregory G., Olsson, Anders G., Abt, Markus, Ballantyne, Christie M., Barter, Philip J., Brumm, Jochen, Chaitman, Bernard R., Holme, Ingar M., Kallend, David, Leiter, Lawrence A., Leitersdorf, Eran, McMurray, John J.V., Mundl, Hardi, Nicholls, Stephen J., Shah, Prediman K., Tardif, Jean-Claude, Wright, R. Scott·2012·New England Journal of Medicine

DOI 10.1056/nejmoa1206797

Cited by (1,004)

Items 701–800 of 1,004

Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Fatima Iqbal, Wendy S. Baker, Madiha Iqbal Khan, Shwetha Thukuntla, Kevin H. McKinney, Nicola I. Abate, Demidmaa Tuvdendorj · 2017 · British Journal of Pharmacology
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?
Philip J. Barter, Stephen James Nicholls, John J.P. Kastelein, K.-A. Rye · 2015 · Circulation
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
Nathalie Pamir, Calvin Pan, Deanna L. Plubell, Patrick M. Hutchins, Chongren Tang, Jake Wimberger, Angela D. Irwin, Thomas Q. de Aguiar Vallim, Jay W. Heinecke, Aldons Jake Lusis · 2019 · Journal of Lipid Research
Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
Yuji Takaeko, Shogo Matsui, Masato Kajikawa, Tatsuya Maruhashi, Shinji Kishimoto, Haruki Hashimoto, Yasuki Kihara, Eisuke Hida, Kazuaki Chayama, Chikara Goto et al. · 2019 · Journal of clinical lipidology
Development and Validation of a Predictive Model for Coronary Artery Disease Using Machine Learning
Chen Wang, Yue Zhao, Bingyu Jin, Xuedong Gan, Bin Liang, Yang Xiang, Xiaokang Zhang, Zhibing Lu, Fang Zheng · 2021 · Frontiers in Cardiovascular Medicine
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
Gunther Marsche, Julia T. Stadler, Julia Kargl, Michael Holzer · 2022 · Antioxidants
HDL does not influence the polarization of human monocytes toward an alternative phenotype
Sophie Colin, Mélanie Fanchon, Loïc Belloy, Andrea E. Bochem, Corinne Copin, Bruno Derudas, Erik S.G. Stroes, G. Kees Hovingh, Jan Albert Kuivenhoven, Geesje M. Dallinga‐Thie et al. · 2014 · International Journal of Cardiology
Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study
Annelise Genoux, Jean‐Bernard Ruidavets, Jean Ferrières, Guillaume Combes, Laeticia Lichtenstein, Véronique Pons, Muriel Laffargue, Dorota Taraszkiewicz, Didier Carrié, Meyer Elbaz et al. · 2013 · Journal of Lipid Research
Atherosclerosis and Transit of HDL Through the Lymphatic Vasculature
Catherine Martel, Gwendalyn J. Randolph · 2013 · Current Atherosclerosis Reports
The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China
Liying Chen, Wenhua Zhu, Linhe Mai, Lizheng Fang, Kejing Ying · 2015 · Atherosclerosis
The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues
Philip D Adamson, Marc Richard Dweck, David Ernest Newby · 2015 · Heart
Rediscovering scavenger receptor type BI: surprising new roles for the HDL receptor
Menno Hoekstra, Mary G. Sorci‐Thomas · 2017 · Current Opinion in Lipidology
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2and HDL3
Kayleigh Griffiths, Agnieszka Pazderska, Mohammed Mahmoud Ahmed, Anne McGowan, Alexander Peter Maxwell, Jane McEneny, James Gibney, Gareth J. McKay · 2017 · Journal of Diabetes Research
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1
Omar Abdel‐Razek, Singh N. Sadananda, Xuan Li, Lubomira Cermakova, Jiri J Frohlich, Liam R. Brunham · 2017 · Journal of clinical lipidology
Is It Time for New Thinking About High-Density Lipoprotein?
Christian Medom Madsen, Børge Grønne Nordestgaard · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
The Remnants of Residual Risk∗
Parag H. Joshi, Seth Shay Martin, Roger Scott Blumenthal · 2015 · Journal of the American College of Cardiology
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
Yonghong Luo, Daoquan Peng · 2023 · Journal of Cardiovascular Pharmacology and Therapeutics
The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease
Nehal N. Mehta, Katerina Dangas, Marc Ditmarsch, Patrick C.N. Rensen, Mary R. Dicklin, John J.P. Kastelein · 2023 · Pharmacological Research
Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes
Traci A. Turner, Evan A. Stein · 2015 · Clinical Therapeutics
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
Evan A. Stein, Frederick Johan Raal · 2016 · Cardiovascular Drugs and Therapy
High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides
Yoshinari Uehara, Giulia Chiesa, Keijiro Saku · 2015 · Circulation Journal
Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study
Annelise Genoux, Laeticia Lichtenstein, Jean Ferrières, Thibaut Duparc, Vanina Bongard, Paul‐Louis Vervueren, Guillaume Combes, Dorota Taraszkiewicz, Meyer Elbaz, Michel Galinier et al. · 2016 · BMC Medicine
Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease
Mark S. Borja, Bradley Hammerson, Chongren Tang, Olga V. Savinova, Gregory C. Shearer, Michael N. Oda · 2017 · PLoS ONE
Mendelian randomization: Its impact on cardiovascular disease
Masa‐aki Kawashiri, Hayato Tada, Akihiro Nomura, Masakazu Yamagishi · 2018 · Journal of Cardiology
LOX-1: A potential driver of cardiovascular risk in SLE patients
Divya Sagar, Ranjitha Gaddipati, Emily L. Ongstad, Nicholas V. Bhagroo, Ling–Ling An, Jingya Wang, Mehdi Belkhodja, Saifur Rahman, Zerai G. Manna, Michael A. Davis et al. · 2020 · PLoS ONE
High-Density Lipoprotein Cholesterol and the Risk of Myocardial Infarction, Stroke, and Cause-Specific Mortality: a Nationwide Cohort Study in Korea
Yeoree Yang, Kyungdo Han, Sang Hyun Park, Mee Kyoung Kim, Kun‐Ho Yoon, Seung‐Hwan Lee · 2021 · Journal of Lipid and Atherosclerosis
The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction
Amarylis Claudine Bonito Azeredo Wanschel, Daniele Mendes Guizoni, Estela Lorza‐Gil, Alessandro Gonzalez Salerno, Adriene Alexandra Paiva, Gabriel G. Dorighello, Ana Paula Davel, Wayne Balkan, Joshua M. Hare, Helena C.F. Oliveira · 2021 · Biomolecules
Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment
Himani Thakkar, Vinnyfred Vincent, Atanu Sen, Archna Singh, Ambuj Roy · 2021 · Journal of Lipids
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
Richard T. George, Liron Abuhatzira, Susan M. Stoughton, Sotirios K. Karathanasis, Dewei She, ChaoYu Jin, Nicholas A. P. S. Buss, Rebecca G Bakker-Arkema, Emily L. Ongstad, Michael J. Koren et al. · 2021 · Journal of the American Heart Association
Genetics of HDL-C: A Causal Link to Atherosclerosis?
Julian C. van Capelleveen, Andrea E. Bochem, M. Mahdi Motazacker, G. Kees Hovingh, John J.P. Kastelein · 2013 · Current Atherosclerosis Reports
Unique Features of High-Density Lipoproteins in the Japanese: In Population and in Genetic Factors
Shinji Yokoyama · 2015 · Nutrients
Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure
Lore Schrutka, Klaus Distelmaier, Philipp J. Hohensinner, Patrick Sulzgruber, Irene Marthe Lang, Gerald Maurer, Johann Wojta, Martin Hülsmann, Alexander Niessner, Lorenz Koller · 2016 · Journal of the American Heart Association
Potent Cholesteryl Ester Transfer Protein Inhibitors of Reduced Lipophilicity: 1,1′-Spiro-Substituted Hexahydrofuroquinoline Derivatives
Thomas Trieselmann, Holger Wagner, Klaus Peter Fuchs, Dieter W. Hamprecht, Daniela G. Berta, Paolo Cremonesi, Rüdiger Streicher, Gerd Luippold, Astrid Volz, Michael Markert et al. · 2014 · Journal of Medicinal Chemistry
Novel lipid modifying drugs to lower LDL cholesterol
Arjen J. Cupido, Laurens F. Reeskamp, John J.P. Kastelein · 2017 · Current Opinion in Lipidology
Lipoprotein apheresis in patients with peripheral artery disease and lipoprotein(a)-hyperlipoproteinemia: 2-year follow-up of a prospective single center study
Wolfram C. Poller, Axel Berger, Henryk Dreger, Stanislao Morgera, Kathrin Enke-Melzer · 2017 · Atherosclerosis Supplements
Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care
Jacob C. Hartz, Sarah D. de Ferranti, Samuel S. Gidding · 2018 · Journal of the Endocrine Society
Relationship between CETP gene polymorphisms with coronary artery disease in Polish population
Joanna Iwanicka, Tomasz Iwanicki, Paweł Niemiec, Anna Balcerzyk, Jolanta Krauze, Sylwia Barbara Górczyńska-Kosiorz, Anna Ochalska-Tyka, Władysław Grzeszczak, Iwona Żak · 2018 · Molecular Biology Reports
Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial
Venu Menon, Anirudh Kumar, Divyang Rajesh Patel, Julie St. John, Jeffrey Riesmeyer, Govinda J. Weerakkody, Giacomo Ruotolo, Kathy Wolski, Ellen Strauss McErlean, Paul C Cremer et al. · 2020 · BMJ Open Diabetes Research & Care
The Impact of Dietary Glycemic Index and Glycemic Load on Postprandial Lipid Kinetics, Dyslipidemia and Cardiovascular Risk
Vaia Lambadiari, Emmanouil Korakas, Vasilis Tsimihodimos · 2020 · Nutrients
HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study
Mohamad O. Ahmed, Rachel Byrne, Agnieszka Pazderska, Ricardo Segurado, Weili Guo, Anjuli Gunness, Isolda Mary Frizelle, Mark Sherlock, Khalid S. Ahmed, Anne McGowan et al. · 2020 · Diabetologia
Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
Veronika Vyletelová, Mária Nováková, Ľudmila Pašková · 2022 · Pharmaceuticals
Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins
Andreas Oberbach, Volker Adams, Nadine S. Schlichting, Marco Heinrich, Yvonne Kullnick, Stefanie Lehmann, Sven Lehmann, Stefan Feder, João Carlos Correia, Friedrich‐Wilhelm Mohr et al. · 2015 · Clinica Chimica Acta
Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments
Elliot M. Berinstein, Andrew P. Levy · 2017 · Expert Opinion on Drug Metabolism & Toxicology
Apolipoprotein A-I and Cholesterol Efflux
Ali Javaheri, Daniel James Rader · 2014 · Circulation Research
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias
Brett Stephen Mansfield, Farzahna Mohamed, Miriam Larouche, Frederick Johan Raal · 2024 · Journal of Clinical Medicine
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
Kausik Kumar Ray, Helle Linnebjerg, Laura F. Michael, Xi Ping Shen, Xiaosu Ma, Shufen Lim, Yuejun Zhen, Henryk Dudek, Marc Abrams, Utsav H. Saxena et al. · 2025 · Journal of the American College of Cardiology
Effects of Niacin Combination Therapy With Statin or Bile Acid Resin on Lipoproteins and Cardiovascular Disease
Alberto Zambon, Xue-Qiao Zhao, B. Greg Brown, John D. Brunzell · 2014 · The American Journal of Cardiology
The bumpy road to evidence: why many research findings are lost in translation
Thomas Felix Lüscher · 2013 · European Heart Journal
Is it AKI or Nonrecovery of Renal Function That Is Important for Long-Term Outcomes?
Steven G. Coca · 2013 · Clinical Journal of the American Society of Nephrology
Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression
Philip G. Joseph, Amorina Ishai, Venkatesh Mani, David G. Kallend, James H F Rudd, Zahi Adel Fayad, Ahmed A Tawakol · 2016 · European Journal of Nuclear Medicine and Molecular Imaging
Cardioprotective Properties of HDL: Structural and Functional Considerations
Eleni T. Pappa, Moses Elisaf, Christina E. Kostara, Eleni Th Bairaktari, Vasilis Tsimihodimos · 2019 · Current Medicinal Chemistry
HDL and Reverse Cholesterol Transport Biomarkers
Kayla A. Riggs, Anand K. Rohatgi · 2019 · Methodist DeBakey Cardiovascular Journal
NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists
Rai Ajit K. Srivastava, Angelo Baldassare Cefalu, Nishtha S. Srivastava, Maurizio Rocco Averna · 2020 · Molecular and Cellular Biochemistry
The Year in Atherothrombosis
Javier Sanz, Pedro Moreno, Valentín Fuster · 2013 · Journal of the American College of Cardiology
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
Andrea Poli, Alberico Luigi Catapano, Alberto Corsini, Enzo Manzato, José Pablo Werba, Gabriele Catena, Irene Cetin, Arrigo F.G. Cicero, Andrea Cignarella, Furio Colivicchi et al. · 2022 · Nutrition Metabolism and Cardiovascular Diseases
Differences in HDL-related mortality risk between individuals with and without hypertension: a prospective cohort study in UK Biobank
Jun‐Xiang Chen, Rui Li, Tingting Geng, Yuexuan Wang, Qi Lu, Zhou‐Zheng Tu, Yue Li, Yun-Fei Liao, Kun Yang, Lirong Zhou et al. · 2023 · European Journal of Preventive Cardiology
High Density Lipoprotein: Assembly, Structure, Cargo, and Functions
Andrew James Murphy · 2013 · ISRN Physiology
Cholesteryl ester transfer protein protects against insulin resistance in obese female mice
David A. Cappel, Brian T. Palmisano, Christopher H. Emfinger, Melissa N. Martinez, Owen P. McGuinness, John M. Stafford · 2013 · Molecular Metabolism
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties
Teja Klančič, Lavinia Woodward, Susanna M. Hofmann, Edward A A Fisher · 2016 · Molecular Metabolism
Impact of Lifestyle Intervention on HDL-Induced eNOS Activation and Cholesterol Efflux Capacity in Obese Adolescent
Jenny Wesnigk, Luc Bruyndonckx, Vicky Y. Hoymans, Ann De Guchtenaere, Tina Fischer, Gerhard C Schuler, Christiaan J. Vrints, Volker Adams · 2016 · Cardiology Research and Practice
Anti-inflammatory drugs as promising cardiovascular treatments
Fabien Huet, Mariama Akodad, Jérémy Fauconnier, Alain Lacampagne, François Roubille · 2016 · Expert Review of Cardiovascular Therapy
Changes in high-density lipoprotein-carried miRNA contribution to the plasmatic pool after consumption of dietary trans fat in healthy men
Véronique Desgagné, Renée Guérin, Simon‐Pierre Guay, François Corbin, Patrick Couture, Benoı̂t Lamarche, Luigi Bouchard · 2017 · Epigenomics
Lipid-lowering treatment in peripheral artery disease
Niki Katsiki, Athanasios D. Giannoukas, Vasilios Gabriel Athyros, Dimitri P. Mikhailidis · 2018 · Current Opinion in Pharmacology
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism
Ryohei Kaseda, Yohei Tsuchida, Hai-Chun Yang, Patricia G. Yancey, Jianyong Zhong, Huan Tao, Aihua Bian, Agnes B. Fogo, MacRae F. Linton, Sergio Fazio et al. · 2018 · BMC Nephrology
Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia
Marjorie Boyer, Patricia L. Mitchell, Paul Poirier, Natalie Alméras, Angelo Tremblay, Jean Bergeron, Jean‐Pierre Després, Benoît J. Arsenault · 2018 · American Journal of Physiology-Endocrinology and Metabolism
CETP‐Inhibition and HDL‐Cholesterol: A Story of CV Risk or CV Benefit, or Both
Stephen James Nicholls · 2018 · Clinical Pharmacology & Therapeutics
Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study
Takashi Miki, Toru Miyoshi, Kazuhiko Kotani, Kunihisa Kohno, Hirohiko Asonuma, Satoru Sakuragi, Yasushi Koyama, Kazufumi Nakamura, Hiroshi Ito · 2019 · Atherosclerosis
Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
Daisuke Yamazaki, Masaru Ishida, Hiroyuki Watanabe, Kiyoshi Nobori, Yasunori Oguma, Yutaka Terata, Takashi Koyama, Kenji Iino, Toshimitsu Kosaka, Hiroshi Ito · 2013 · Lipids in Health and Disease
Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults
Huifan Huang, Bin Yang, Renhe Yu, Wen Ouyang, Jianbin Tong, Yuan Le · 2024 · Nutrition Journal
Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk
Davide Noto, Angelo Baldassare Cefalu, Maurizio Rocco Averna · 2014 · Current Atherosclerosis Reports
High-Density Lipoproteins
Arash Haghikia, Ulf Landmesser · 2018 · Cardiology Clinics
High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility
Laura Z. Vanags, Nathan K. P. Wong, Stephen James Nicholls, Christina A. Bursill · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
Kidney as modulator and target of “good/bad” HDL
Jianyong Zhong, Haichun Yang, Valentina Kon · 2018 · Pediatric Nephrology
Residual cardiovascular risk among people with diabetes
Satya Dash, Lawrence A. Leiter · 2019 · Diabetes Obesity and Metabolism
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
John E. Le Lay, Qun Du, Minal B. Mehta, Nicholas V. Bhagroo, B. Timothy Hummer, Judith Falloon, Glenn F. Carlson, Anton I. Rosenbaum, ChaoYu Jin, Holly H. C. Kimko et al. · 2021 · Science Translational Medicine
Inherited Variants in SCARB1 Cause Severe Early-Onset Coronary Artery Disease
Sara N. Koenig, Holly C. Sucharski, Elizabeth M. Jose, Emma K. Dudley, Francesca Madiai, Omer Cavus, Aaron D. Argall, Jordan L. Williams, Nathaniel P. Murphy, Caullin B. R. Keith et al. · 2021 · Circulation Research
Different associations between HDL cholesterol and cardiovascular diseases in people with diabetes mellitus and people without diabetes mellitus: a prospective community-based study
Zhijun Wu, Zhe Huang, Alice Hinda Lichtenstein, Cheng Jin, Shuohua Chen, Shouling Wu, Xiang Gao · 2021 · American Journal of Clinical Nutrition
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Carmelita Abrahams, Nicholas J. Woudberg, Sandrine Lecour · 2022 · Lipids in Health and Disease
Dyslipidemia: A Narrative Review on Pharmacotherapy
Lucas Dorneles de Oliveira, Arthur Cicupira Rodrigues de Assis, Viviane Zorzanelli Rocha Giraldez, Thiago Luis Scudeler, Paulo Rogério Soares · 2024 · Pharmaceuticals
Prevention of Chronic Kidney Disease and Subsequent Effect on Mortality: A Systematic Review and Meta-Analysis
Usman Khan, Amit X. Garg, Chirag R. Parikh, Steven G. Coca · 2013 · PLoS ONE
HDL quality or cholesterol cargo
Emmanuel Eroume A Egom, Mamas A. Mamas, Handrean Soran · 2013 · Current Opinion in Lipidology
Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages
Shigeyasu Tsuda, Masakazu Shinohara, Toshihiko Oshita, Manabu Nagao, Nobuaki K. Tanaka, Takeshige Mori, Tetsuya Hara, Yasuhiro Irino, Ryuji Toh, Tatsuro Ishida et al. · 2017 · Scientific Reports
ESRD ‐induced dyslipidemia—Should management of lipid disorders differ in dialysis patients?
Hamid Moradi, Elani Streja, Nosratola D. Vaziri · 2018 · Seminars in Dialysis
Most Promising Therapies in Interventional Cardiology
Mathieu Kernéis, Tarek Nafee, Megan K. Yee, Hassan A. Kazmi, Sudarshana Datta, Michel Zeitouni, M. Khurram Afzal, Mehrian Jafarizade, Sargun Singh Walia, Iqra Qamar et al. · 2019 · Current Cardiology Reports
Whole egg consumption compared with yolk-free egg increases the cholesterol efflux capacity of high-density lipoproteins in overweight, postmenopausal women
Lisa Sawrey‐Kubicek, Chenghao Zhu, Allison S. Bardagjy, Christopher H Rhodes, Romina Sacchi, Jody Randolph, Francene M. Steinberg, Angela M. Zivkovic · 2019 · American Journal of Clinical Nutrition
Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans
Allison B. Andraski, Sasha A. Singh, Lang Ho Lee, Hideyuki Higashi, Nathaniel Smith, Bo Zhang, Masanori Aikawa, Frank M. Sacks · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
New therapies to reduce low-density lipoprotein cholesterol
Anthony S. Wierzbicki, Adie Viljoen, Timothy Colin Hardman, Dimitri P. Mikhailidis · 2013 · Current Opinion in Cardiology
Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities
Kyriakos E. Kypreos, Rafael Bitzur, Eleni A. Karavia, Eva Xepapadaki, George D. Panayiotakopoulos, Caterina Constantinou · 2018 · Angiology
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients.
Yi Li, Ting-Hsing Chao, Ping Yen Liu, Kwo Chang Ueng, Hung I. Yeh · 2018 · Europe PMC (PubMed Central)
Impaired Cholesterol‐Uptake Capacity of HDL Might Promote Target‐Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation
Yuichiro Nagano, Hiromasa Otake, Takayoshi Toba, Koji Kuroda, Yuto Shinkura, Natsuko Tahara, Yoshiro Tsukiyama, Kenichi Yanaka, Hiroyuki Yamamoto, Akira Nagasawa et al. · 2019 · Journal of the American Heart Association
Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasis
Evangelia Zvintzou, Eva Xepapadaki, Christina P Kalogeropoulou, Serafoula Filou, Kyriakos E. Kypreos · 2019 · Journal of Biomedical Research
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study
Capucine Bertrand, Pierre‐Jean Saulnier, Louis Potier, Mikaël Croyal, Valentin Blanchard, Elise Gand, Stéphanie Ragot, Fabrice M. Schneider, Olivia Bocock, Laurence Baillet‐Blanco et al. · 2021 · Diabetologia
Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses
Maxime M. Bos, Neil Goulding, Matthew A. Lee, Amy Hofman, Mariska Bot, René Pool, Lisanne S. Vijfhuizen, Xiang Zhang, Chihua Li, Rima Mustafa et al. · 2021 · BMC Medicine
High-Density Lipoproteins in Kidney Disease
Valentina Kon, Haichun Yang, Loren E. Smith, Kasey C. Vickers, MacRae F. Linton · 2021 · International Journal of Molecular Sciences
Inflammation Alters Relationship Between High‐Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW‐CKD
Jae Young Kim, Jung Tak Park, Hyung Woo Kim, Tae Ik Chang, Ea Wha Kang, Curie Ahn, Kook‐Hwan Oh, Joongyub Lee, Wookyung Chung, Yong‐Soo Kim et al. · 2021 · Journal of the American Heart Association
Effect of Isoenergetic Substitution of Cheese with Other Dairy Products on Blood Lipid Markers in the Fasted and Postprandial State: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults
Rebecca Pradeilles, Tom Norris, Laury Sellem, Oonagh Markey · 2023 · Advances in Nutrition
Update of HDL in atherosclerotic cardiovascular disease
Leonie Schoch, Sebastià Alcover, Teresa Padró, Soumaya Ben‐Aicha, Guiomar Mendieta, Lina Badimón, Gemma Vilahur · 2023 · Clínica e Investigación en Arteriosclerosis
Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Wajeeh Ur Rehman, Merav Yarkoni, Muhammad Abdullah Ilyas, Farwa Athar, Mahnoor Javaid, Muhammad Tauqeer Ehsan, Muhammad Talha Khalid, Ahmed Khurshid Pasha, Abdelhamid Ben Selma, Alon Yarkoni et al. · 2024 · Journal of Cardiovascular Development and Disease
High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases
Masahiro Ikenaga, Yasuki Higaki, Keijiro Saku, Yoshinari Uehara · 2016 · Journal of Atherosclerosis and Thrombosis
Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses
Annette Graham · 2015 · World Journal of Cardiology